HCG and clomiphene citrate and their effect on semen analysis parameters

The effect of HCG and clomiphene citrate on semen parameters in men with severe Oligoasthenospermia

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180307038986N1

Enrollment

Registered

2018-04-24

Start date

2018-01-21

Completion date

Unknown

Last updated

2018-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Male Infertility. Male infertility

Interventions

Intervention 1: Intervention group:Group one will be treated by 50 mg/PO/OD clomiphene citrate for 3 months. Intervention 2: Intervention group: Group 2 will be treated by 2500 U HCG/IM 3 times in wee

Eligibility

Sex/Gender

Male

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Severe Oligoasthenospermia Sperm count less than 5 million Male infertility

Exclusion criteria

Exclusion criteria: Male infertility due to a definite etiology Sever Oligoasthenospermia due to a definite etiology simultaneously consumption of the drugs that can affect male fertility (Testosterone, Steroids, Cimetidine, ...)

Design outcomes

Primary

Measure	Time frame
Semen volume, sperm count, the percent of abnormal sperms, the percent of motile sperms. Timepoint: Before the trial, 3 months after trial start. Method of measurement: Semen analysis.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Hossein Abdi

Kermanshah University of Medical Sciences

hossein.abdi@kums.ac.ir+98 83 3427 6300

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026